ABOS
Price
$1.50
Change
+$0.02 (+1.35%)
Updated
Jul 18 closing price
Capitalization
90.86M
28 days until earnings call
TLPPF
Price
$15.90
Change
+$0.13 (+0.82%)
Updated
Jul 18 closing price
Capitalization
5.52B
Interact to see
Advertisement

ABOS vs TLPPF

Header iconABOS vs TLPPF Comparison
Open Charts ABOS vs TLPPFBanner chart's image
Acumen Pharmaceuticals
Price$1.50
Change+$0.02 (+1.35%)
Volume$512.02K
Capitalization90.86M
Telix Pharmaceutical
Price$15.90
Change+$0.13 (+0.82%)
Volume$2.16K
Capitalization5.52B
ABOS vs TLPPF Comparison Chart in %
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. TLPPF commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and TLPPF is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (ABOS: $1.50 vs. TLPPF: $15.90)
Brand notoriety: ABOS and TLPPF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 102% vs. TLPPF: 49%
Market capitalization -- ABOS: $90.86M vs. TLPPF: $5.52B
ABOS [@Biotechnology] is valued at $90.86M. TLPPF’s [@Biotechnology] market capitalization is $5.52B. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileTLPPF’s FA Score has 1 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • TLPPF’s FA Score: 1 green, 4 red.
According to our system of comparison, TLPPF is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 4 TA indicator(s) are bullish while TLPPF’s TA Score has 4 bullish TA indicator(s).

  • ABOS’s TA Score: 4 bullish, 4 bearish.
  • TLPPF’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, both ABOS and TLPPF are a good buy in the short-term.

Price Growth

ABOS (@Biotechnology) experienced а +7.14% price change this week, while TLPPF (@Biotechnology) price change was +4.26% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TLPPF($5.52B) has a higher market cap than ABOS($90.9M). TLPPF YTD gains are higher at: 6.177 vs. ABOS (-12.791). TLPPF has higher annual earnings (EBITDA): 92.5M vs. ABOS (-111.98M). TLPPF has more cash in the bank: 710M vs. ABOS (149M). ABOS has less debt than TLPPF: ABOS (29M) vs TLPPF (581M). TLPPF has higher revenues than ABOS: TLPPF (783M) vs ABOS (0).
ABOSTLPPFABOS / TLPPF
Capitalization90.9M5.52B2%
EBITDA-111.98M92.5M-121%
Gain YTD-12.7916.177-207%
P/E RatioN/A168.57-
Revenue0783M-
Total Cash149M710M21%
Total Debt29M581M5%
FUNDAMENTALS RATINGS
TLPPF: Fundamental Ratings
TLPPF
OUTLOOK RATING
1..100
85
VALUATION
overvalued / fair valued / undervalued
1..100
88
Overvalued
PROFIT vs RISK RATING
1..100
18
SMR RATING
1..100
74
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSTLPPF
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
82%
Momentum
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
70%
MACD
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
65%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
78%
Declines
ODDS (%)
Bearish Trend 24 days ago
88%
Bearish Trend 10 days ago
68%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
83%
Aroon
ODDS (%)
Bullish Trend 3 days ago
72%
Bearish Trend 3 days ago
57%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TLPPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
YNAJF2.301.48
+180.49%
Yantai North Andre Juice Co., Ltd.
SCIA4.480.23
+5.41%
SCI Engineered Materials, Inc.
NBCDF18.560.06
+0.34%
National Bank of Canada
IFSUF12.43N/A
N/A
Infrastrutture Wireless Italiane SPA Azioni
MRCIF15.88N/A
N/A
Mercari Inc.

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with CRBU. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then CRBU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
+1.35%
CRBU - ABOS
52%
Loosely correlated
+12.02%
GLSI - ABOS
52%
Loosely correlated
-5.77%
FHTX - ABOS
50%
Loosely correlated
+0.49%
BEAM - ABOS
50%
Loosely correlated
+1.47%
SYRE - ABOS
49%
Loosely correlated
-3.55%
More

TLPPF and

Correlation & Price change

A.I.dvisor tells us that TLPPF and BDTX have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TLPPF and BDTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TLPPF
1D Price
Change %
TLPPF100%
+0.81%
BDTX - TLPPF
22%
Poorly correlated
-2.49%
ITOS - TLPPF
21%
Poorly correlated
N/A
RCUS - TLPPF
21%
Poorly correlated
-2.87%
ORMP - TLPPF
21%
Poorly correlated
N/A
ABOS - TLPPF
20%
Poorly correlated
+1.35%
More